InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Baumal Caroline, Chief Medical Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 11 filings have been published. Split: 0 buy · 6 sells. Total volume traded: €447k. History available since 3 January 2023. The latest transaction was disclosed on 29 April 2026 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Baumal Caroline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
86,525 sharesCommon StockSEC:0001193125-26-224577:0
900 shares0Common StockSEC:0001492422-26-000105:0
2,797 shares@ US$21.765411.7% of flowCommon StockSEC:0001492422-26-000061:0
1,882 shares@ US$19.79297.2% of flowCommon StockSEC:0001492422-26-000045:0
3,020 shares@ US$25.528714.7% of flowCommon StockSEC:0001492422-26-000016:0
1,853 shares@ US$29.958218.1% of flowCommon StockSEC:0001127602-25-001612:0
39,594 shares0Common StockSEC:0001127602-25-001612:1
2,816 shares@ US$33.81231.1% of flowCommon StockSEC:0001127602-25-001011:0
25,445 shares0Common StockSEC:0001127602-24-001432:0
2,751 shares@ US$60.053450.8% of flowCommon StockSEC:0001127602-24-000962:0
35,549 shares0Common StockSEC:0001127602-23-001003:0
11 of 11 declarations
About Baumal Caroline
Caroline Baumal is the Chief Medical Officer at Apellis Pharmaceuticals, Inc. In this role, she is responsible for the medical and clinical aspects of the company's products. Her medical expertise is essential to ensure the safety and efficacy of the treatments developed by Apellis.
